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Previously published studies revealed that variation in expression of
the DNA-binding protein ARID3a in B lymphocytes from patients with
systemic lupus erythematosus (SLE) correlated with levels of disease
activity (“Disease activity in systemic lupus erythematosus correlates
with expression of the transcription factor AT-rich-interactive domain
3A” (J.M. Ward, K. Rose, C. Montgomery, I. Adrianto, J.A. James,
J.T. Merrill et al., 2014) [1]). The data presented here compare DNA
methylation patterns from SLE peripheral blood mononuclear cells
obtained from samples with high numbers of ARID3a expressing B
cells (ARID3aH) versus SLE samples with normal numbers of ARID3aþ
B cells (ARID3aN). The methylation data is available at the gene
expression omnibus (GEO) repository, “Gene Expression Omnibus:
NCBI gene expression and hybridization array data repository”vier Inc. This is an open access article under the CC BY license
/j.jaut.2016.08.003
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J.M. Ward et al. / Data in Brief 9 (2016) 213–219214(R. Edgar, M. Domrachev, A.E. Lash, 2002) [2]. Isolated B cells from SLE
ARID3aH and ARID3aN B samples were also evaluated via qRT-PCR for
Type I interferon (IFN) signature and pathway gene expression levels
by qRT-PCR. Similarly, healthy control B cells and B cells stimulated to
express ARID3a with the TLR agonist, CpG, were also compared via
qRT-PCR. Primers designed to detect 6 IFNa subtype mRNAs were
tested in 4 IFNa, Epstein-Barr Virus-transformed B cell lines (“Reduced
interferon-alpha production by Epstein-Barr virus transformed
B-lymphoblastoid cell lines and lectin-stimulated lymphocytes in
congenital dyserythropoietic anemia type I” (S.H. Wickramasinghe,
R. Hasan, J. Smythe, 1997) [3]). The data in this article support the
publication, “Human effector B lymphocytes express ARID3a and
secrete interferon alpha” (J.M. Ward, M.L. Ratliff, M.G. Dozmorov,
G. Wiley, J.M. Guthridge, P.M. Gaffney, J.A. James, C.F. Webb, 2016) [4].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Immunology
ore speciﬁc sub-
ject areaSLE and ARID3aþ B cellsype of data Figure, Tables, link
ow data was
acquiredElectrophoresis and BIOMARK HData format Raw, analyzed
xperimental
factorsFACS-puriﬁed SLE and healthy B lymphocytes (þ /- CpG-stimulation)xperimental
featuresDNA was isolated from ARID3aH and ARID3aN total PBMCs; RNA was extracted
from LCLs, peripheral blood SLE B cells, and healthy control B cells with or
without CpG-stimulation for 24 hours.ata source
locationOklahoma City, OK; USAata accessibility Data is available within this article and deposited in NCBI's Gene Expression
Omnibus http://www.ncbi.nlm.nih.gov/geo/ accessible via GEO series
accession number: GEO: GSE84965Value of the data
 DNA gene methylation data derived from SLE peripheral blood mononuclear cells were subdivided
based on levels of ARID3a expression, a transcription factor which correlated with disease activity
indices [1], allowing comparison of patient samples with high and low ARID3a levels.
 Data for expression of a subset of IFNa associated genes obtained from SLE samples with high or
low ARID3a expression, and from healthy control blood cells or those stimulated to express
increased levels of ARID3a, allow comparison of effects of high and low ARID3a expression on gene
expression.
 Data provide validation of primer sets useful for studying Type I interferon signature genes.
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One database link, three tables, and one ﬁgure are provided in this article. Methyl-seq data from
SLE PBMCs segregated based on high or normal numbers of ARID3aþ B cells was deposited in NCBI's
GEO database under the following accession number GEO: GSE84965 [2]. Tables 1 and 2 show qRT-
PCR data obtained via Biomark HD for Type I IFN pathway genes from RNA derived from SLE B cells
subdivided based on ARID3a levels [1], and for healthy control B cells with or without CpG induced
ARID3a expression [4]. IFN signature genes are in bold. Primers for RT-PCR and qRT-PCR are given in
Table 3. Fig. 1 shows the results of RT-PCR of IFNa in four EBV-transformed lymphoblastoid B cell
lines [3].2. Experimental design, materials and methods
2.1. Peripheral blood cells and cell lines
Total peripheral blood mononuclear cells (PBMCs) were obtained via Ficoll puriﬁcation, and were
stained for the pan-B cell marker CD20 and intracellular ARID3a prior to analyses by ﬂow cytometry,
as previously described [1]. These data allowed subdivision of SLE samples into ARID3a high and
ARID3a normal patient samples, such that ARID3aH SLE samples had numbers of ARID3aþ B cells 42
standard deviations above the average numbers of ARID3aþ B cells in healthy controls (49830
ARID3aþ B cells/ml), versus ARID3aN (o9830 ARID3aþ B cells/ml), as deﬁned previously [1]. B
lymphocytes puriﬁed by ﬂow cytometric sorting (497% purity via post-sort analyses) were used
immediately for RNA preparation in the case of SLE samples, or in the case of healthy control cells,Table 1
Upregulated genes in ARID3aH versus ARID3aN SLE B cells.
Gene ARID3aH ARID3aN P-value
ARID3a 0.6843 0.0692 0.0008
BCL2 4.6000 1.3283 0.0081
BCL2L1 7.6980 0.3608 0.0049
EPSTI1 1958.1900 17.6625 0.0034
HERC5 17.4250 1.9833 0.0043
IFI6 46.0745 3.7483 0.0227
IFI27 1958.1900 17.6625 0.0034
IFI44 23.6242 16.6467 0.3387
IFI44L 130.6440 29.8092 0.0369
IFIT3 33.2118 14.8208 0.0691
IFNA2 49.0570 22.9925 0.2194
IFNAR1 1.0425 1.2433 0.5319
IFNB1 9.3942 1.1575 0.0004
IRF3 2.1863 0.1408 0.0008
IRF5 1.3742 0.3783 0.0035
IRF7 3.5360 0.2510 0.0006
ISIG15 5.6233 0.6150 0.0118
Ly6E 21.4388 1.5683 0.0023
MX1 33.6467 4.3542 0.0009
MYD88 4.1236 2.2740 0.0999
OAS1 11.7725 0.3267 0.0007
OAS2 0.8475 0.2542 0.0847
OAS3 6.0257 0.2313 0.0018
PLSCR1 17.5975 0.8400 0.0526
SIGLEC1 144.2100 55.8713 0.0570
STAT1 2.2225 1.0158 0.0660
TLR 7 5.7500 2.0808 0.0165
TLR9 3.8250 2.8425 0.4706
USP18 17.5975 0.8400 0.0010
Table 2
Upregulated or downregulated genes in CpG-stimulated versus unstimulated healthy control B cells.
Gene CpG Unstimulated P-value
Upregulated
EPST1 3.14125 1.01875 o0.000001
HERC5 6.9225 0.9875 o0.000001
IFI6 1.95 1.00125 0.001894
IFI27 4.9 1.58 0.001146
IFI44 1.805 1.05125 0.003712
IFI44L 2.2325 1.23 0.001263
IFIT3 3.06375 1.19625 0.000121
IFNA2 3.16625 1.07125 0.015070
IFNAR1 2.12 1.0075 o0.000001
IFNB1 3.3125 1.325 0.017893
IRF3 1.94875 1.01875 o0.000001
IRF5 1.01375 1.04125 0.710859
IRF7 1.5325 0.98625 o0.000001
ISG15 0.7825 0.8975 0.385249
Ly6E 1.6825 1.015 0.000261
MX1 2.61125 1.0375 0.000002
MYD88 1.31125 0.96625 0.000083
OAS1 4.3175 0.945 o0.000001
OAS2 1.7975 0.99 0.000954
OAS3 2.1375 1.0725 0.001380
PLSCR1 1.5125 0.99625 0.000332
STAT1 1.0025 1.01375 0.808948
TLR7 5.30625 1.0375 0.000002
TLR9 2.28375 0.99875 0.001518
Downregulated
BCL2L1 0.7475 0.9525 0.009423
IFN signature genes are in bold.
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100 mg/ml streptomycin, 2 mM glutamine and 1 mM sodium pyruvate) supplemented with 4% heat
inactivated fetal bovine serum (FBS), with or without 5 mg/ml Class CpG oligonucleotide for 24 h, as
previously described [4]. Epstein-Barr Virus (EBV)-transformed lymphoblastoid B cell lines (LCLs)
were generated from 4 SLE patient samples and maintained in complete RPMI media.
2.2. Methyl-seq
To determine if increased expression of ARID3a within SLE patient samples was associated with
alterations in DNA methylation, genomic DNA was isolated using standard phenol/Chloroform
extraction protocols from total PBMCs obtained from each of two SLE patient samples characterized
as ARID3aH and two independent SLE samples characterized as ARID3a low. DNA was fragmented on
a Covaris S2 sonicator (Covaris, Woburn, MA) to an average size of 350 bp in length and methylated
DNA was isolated using the MethylMiner Methylated DNA Enrichment Kit (Life Technologies,
Carlsbad, CA). Illumina sequencing libraries were prepared from each sample using the Illumina
Truseq DNA LT Sample Prep Kit (Illumina, San Diego, CA) by the Genomics Core facility at Oklahoma
Medical Research Foundation. Libraries were sequenced on an Illumina Hiseq 2000 instrument with
paired-end 100 bp reads. Quality control metrics were assessed with Picard tools v. (https://broad
institute.github.io/picard/). After sequencing, reads were aligned to the human reference genome
hg19 using the aligner BWA-MEM [5] followed by local realignment around problematic indel
sequences using the Genome Analysis Tool Kit (GATK) [6]. Genes with statistically signiﬁcant
methylation differences were deﬁned using EpiCenter v. 1-6-1-8 [7]. Methylation differences were
tested over promoters of the genes, deﬁned as 2000 bp regions upstream of gene’ transcription start
sites. The differentially methylated regions were visualized in the IGV integrative genomics viewer
Table 3
Primer sequences.
Gene Primer sequence (50 to 30) Figure
IFIT1 CTCCTTGGGTTCGTCTATAAATTG
AGTCAGCAGCCAGTCTCAG
Fig. 1a in [4]
HPRT1 TTGGTCAGGCAGTATAATCC
GGGCATATCCTACAACAAAC
Fig. 1a in [4]
GAPDH GCCGCATCTTCTTTTGCGT
GCCCAATACGACCAAATCCGT
Fig. 1a in [4]
CMYC ACTCTGAGGAGGAACAAGAA
TGGAGACGTGGCACCTCTT
Fig. 1e in [4]
ARID3A AACAAGAAGCTGTGGCGTGA
TCATGTATTGGGTCCGCAGG
Fig. 1c in [4]
ACTIN ATCTGGCACCACACCTTCTACAATGAGCTGCG
CGTCATACTCCTGCTTGCTGATCCACATCTGC
Fig. 1
IFNA CCTGGCACAAATGAGGAGAA
AGCTGCTGGTAAAGTTCAGTATAG
Fig. 2a in [4]
Fig. 1
OAS1 TACCCTGTGTGTGTGTCCAA
AGAGGACTGAGGAAGACAACC
Fig. 3a, 4d in
[4] Table 1
OAS2 TGGTGAACACCATCTGTGAC
CCATCGGAGTTGCCTCTTAA
OAS3 AGGACTGGATGGATGTTAGCC
ACTTGTGGCTTGGGTTTGAC
Table 1
ISG15 CTGAGAGGCAGCGAACTCA
GCTCAGGGACACCTGGAA
Table 1
PLSCR1 GTTGTCCCTGCTGCCTTCA
TGGGTGCCAAGTCTGAATAACA
Table 2
HERC5 TTCAGATCACATGTGGAGATTACC
GTTCTGTCCCCAGGCAAAA
Tables 1,2
IFI44 GGCTTTGGTGGGCACTAATA
TGCCATCTTTCCCGTCTCTA
IFIT3 ACTGGCAATTGCGATGTACC
GCTCAATGGCCTGCTTCAAA
Table 2
LY6E TGCTCCGACCAGGACAACTA
GGCTGTGGCCAAATGTCAC
Tables 1,2
MX1 ATGCTACTGTGGCCCAGAAA
GGCGCACCTTCTCCTCATA
Tables 1,2
USP18 TGAATGTGGACTTCACCAGGATA
GCAGCAGAAGCATCTGGAAA
Table 1
IFI44L GCAAAAGTGAAGCAAGTTCACA
GAACCTCACTGCAATCATCCA
Tables 1,2
IFI6 TGCTACCTGCTGCTCTTCA
TCAGGGCCTTCCAGAACC
Table 1
SIGLEC1 AGGAGGCGTGTTTGTAAGCA
TGTGGCTGCATCAGGATCAA
Fig. 3a in [4]
IFI27 TTGTGGCTACTCTGCAGTCA
CCCAGGATGAACTTGGTCAA
Table 1
EPSTI1 GCAAGAGCAAGAAAGAGCCAAA
CCTTGGAGTCGGTCCAGAAAA
Tables 1,2
IRF3 ACCAATGGTGGAGGCAGTAC
TGGGGCCAACACCATGTTA
Fig. 3b, 4e in
[4]
IRF5 AGATCTACGAGGTCTGCTCCAA
CCTCTCCTGCACCAAAAGAGTA
IRF7 GGCAGAGCCGTACCTGTCA
ACCGTGCGGCCCTTGTA
TLR7 TCTTCAACCAGACCTCTACATTCC
AGCCCCAAGGAGTTTGGAAA
Tables 1,2
TLR9 TGCAACTGGCTGTTCCTGAA
ACAAGGAAAGGCTGGTGACA
Table 2
MYD88 CTGCAGAGCAAGGAATGTGAC
TGCTGGGGAACTCTTTCTTCA
IFNAR1 AGTGACGCTGTATGTGAGAAAA
ACGGGAGAGCAAATAATGCA
Fig. 3b in [4]
Table 2
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Table 3 (continued )
Gene Primer sequence (50 to 30) Figure
STAT1 ATGCTGGCACCAGAACGAA
GCTGGCACAATTGGGTTTCAA
IFNA2 AGGATTCAGCGGGAACACAA
CAATCTCAAACTCTGGTGGTTCAAA
Table 2
IFNB1 ATGAGCAGTCTGCACCTGAA
GACTGTACTCCTTGGCCTTCA
Table 2
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Fig. 1. EBV-transformed lymphoblastoid B cell lines (LCLs) express IFNa. RT-PCR analysis of IFNa expression in 4 distinct
EBV-transformed lymphoblastoid lines was measured in comparison to the positive control cell line, 293T. A no template (NT)
negative control is also shown. The housekeeping gene, β-actin, was ampliﬁed to demonstrate relative levels of IFNa RNA in
each cell line.
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using a combination of BEDTools [9] and UCSC conversion utilities [10].2.3. Biomark HD assays
Peripheral blood mononuclear cells were isolated from peripheral blood of 6 SLE patients and
2 healthy individuals, and were analyzed for ARID3a expression as described above by ﬂow
cytometry. B lymphocytes were enriched from the remaining PBMCs via negative selection using
magnetic beads containing other lineage markers, and the remaining cells were stained with CD20 for
ﬂuorescence activated cell sorting (FACS) using a FACSAria II (BD Biosciences). Post-sort analyses
revealed 498% CD20þ B lymphocytes. RNA was isolated, quantiﬁed and assessed for integrity using
Agilent Total RNA Pico chips on the 2100 Bioanalyzer (Agilent Technologies, Boblingen, Germany). The
DELTAgene assay designer was used for primer design for optimal performance on the Biomark HD
system. Primer speciﬁcity was determined via melting curve analysis at 400 nM. cDNA preparation
(Fluidigm preamp master mix, PM100-5580), ampliﬁcation (Fluidigm, DELTAgene assay kit), qRT-PCR
and analyses were all performed as previously described [11]. Data in Tables 1 and 2 are normalized to
the housekeeping gene Hprt1. A list of primers for the genes assessed is given in Table 3.2.4. IFNa analyses of EBV lines
For qRT-PCR, RNA was extracted using Tri-Reagent (MRC, Inc.) and chloroform:isoamyl alcohol
24:1 (Sigma), precipitated in isopropanol, and collected via centrifugation. cDNA was synthesized at
37 °C for 1 h with M-MLV reverse transcriptase (Promega) and random primers (Promega), and
ampliﬁed for 40 cycles at 60 °C for 30 s, 72 °C for 1 min, and 95 °C for 30 s for IFNa (IFNA2, IFNA5,
IFNA6, IFNA8, IFNA14, IFNA16) gene expression. Ampliﬁed products were electrophoresed through 2%
agarose gel.
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